EASEE-LEE – European Long-Term Study on the Use of the EASEE® System for Focal Epilepsy
Long-Term Experience with the EASEE® System for Focal Epilepsy across Europe
This prospective registry generates long-term data on disease progression, seizure control, and patient-relevant outcomes under transcranial focal cortex stimulation with EASEE®, providing real-world evidence to inform clinical practice.
People with Epilepsy at the Center
The EASEE-LEE study provides important insights into how the EASEE® System can support people with focal epilepsy over the long term.
Clinical Benefits in Focus
The study generates real-world data on the use of the EASEE® System in Europe, complementing clinical evidence from earlier studies.
Long-Term Data with Real-World Relevance
Over a five-year follow-up period, the EASEE-LEE study will evaluate seizure outcomes, safety, quality of life, and device performance in clinical practice.
The Study at a Glance
- Indication: Drug-resistant focal epilepsy
- Population: 40 adult patients aged 18 and older
- Intervention: Treatment with the EASEE® System as part of routine clinical care
- Study Design: Prospective, open-label, multicenter, international registry study
- Objective: Evaluation of the long-term efficacy, safety, and clinical performance of the EASEE® System
Study Overview
Enrollment
Baseline
Implantation
Activation
Follow-up
Study End
Want to learn more about the EASEE-LEE Study?
Further details on the study design, eligibility criteria, and study sites can be found in the official study registry entry.
The Expert behind EASEE-LEE
Priv.-Doz. Dr. med. Elisabeth Kaufmann
Senior Consultant, Department of Neurology, LMU University Hospital Munich
Interested in the EASEE-LEE study?
For questions about EASEE-LEE, the study team is happy to help.
